Painless effect in upper extermity surgeries.
Conditions
Interventions
Intervention 1: Group 1 case:40 cc lidocain 0/5 % 3 mg/kg and record pain in 5-10-15-30-45 and 60 minutes with VAS in upper limbs. Intervention 2: Group 2 control:40 cc lidocain 0/5 % 3 mg/kg with 0/5
Treatment - Drugs
Group 1 case:40 cc lidocain 0/5 % 3 mg/kg and record pain in 5-10-15-30-45 and 60 minutes with VAS in upper limbs.
Group 2 control:40 cc lidocain 0/5 % 3 mg/kg with 0/5mg atracorium and record pain in 5-10-15-30-45 and 60 minutes with VAS in upper limbs.
Group 3 control:40 cc lidocain 0/5 % 3 mg/kg with fentanyl 1mic/kg and record pain in 5-10-15-30-45 and 60 minutes with VAS in upper limbs.
Sponsors
Golestan University of Medical Sciences/ department of science and technology
Eligibility
Sex/Gender
All
Age
15 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients older than 15 and younger than 60 years and ?? ASA physical status of ASA? and upper extremity surgery. Patients with a history of cardiovascular disease, allergy to local anesthetic, hypertensive, obese patients (BMI> 35), with a history of peripheral vascular disease such as scleroderma, severe Raynaud's, epilepsy, polyneuropathy, sickle cell disease, methemoglobinemia inflammation and cellulitis skin infection will be excluded .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Painlessness. Timepoint: One month. Method of measurement: VAS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug toxicity. Timepoint: One month. Method of measurement: Clinical assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Hamid Reza Asadi
Golestan University of Medical Sciences
Outcome results
None listed